Option Care Health price target raised to $37 from $36 at JMP Securities

JMP Securities raised the firm’s price target on Option Care Health to $37 from $36 and keeps an Outperform rating on the shares. The firm expects Option Care to navigate through Stelara erosion the same way that it has in other therapeutic events and believes the company, as the largest home infusion provider, would offer compelling synergies with a variety of post-acute service entities, the analyst tells investors in a research note.